This compound is a modified nucleoside building block featuring a protected ribofuranose core with a fluorine substitution and a uracil base. It is primarily used as a synthetic intermediate in pharmaceutical research for the preparation of modified oligonucleotides.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 146954-74-7
5'-O-[bis(4-methoxyphenyl)phenylmethyl]uridine
protected nucleoside for oligonucleotide synthesis
5'-O-(Bis(4-methoxyphenyl)(phenyl)methyl)-2'-O-methyluridine
research compound for oligonucleotide synthesis
5'-O-DMT-2'-TBDMS-Uridine
protected uridine for oligonucleotide synthesis
Triethylamine 4-(((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-3-yl)oxy)-4-oxobutanoate
Research reagent
3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(2,4-dioxopyrimidin-1-yl)-4-fluorooxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
modified nucleotide synthesis intermediate
Mirogabalin Impurities N75
pharmaceutical impurity reference standard
(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-6-{[(prop-2-en-1-yloxy)carbonyl]amino}hexanoic acid
Protected amino acid for peptide synthesis
Dapagliflozin Impurity 9
Pharmaceutical impurity reference standard
1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-4-hydroxyoxolan-2-yl]pyrimidine-2,4-dione
CSSFZSSZXOCCJB-YULOIDQLSA-N
COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=CC(=O)NC5=O)F)O